WallStreetZenWallStreetZen

NASDAQ: ALNY
Alnylam Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ALNY

Based on 12 analysts offering 12 month price targets for Alnylam Pharmaceuticals Inc.
Min Forecast
$150.00+4.38%
Avg Forecast
$213.58+48.62%
Max Forecast
$395.00+174.86%

Should I buy or sell ALNY stock?

Based on 12 analysts offering ratings for Alnylam Pharmaceuticals Inc.
Buy
Strong Buy
3 analysts 25%
Buy
4 analysts 33.33%
Hold
5 analysts 41.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALNY stock forecasts and price targets.

ALNY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-05
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2024-02-16
Citigroup
Bottom 10%
10
Strong BuyMaintains$227.00+57.96%2024-02-16
Chardan Capital
Top 5%
96
Strong BuyMaintains$225.00+56.57%2024-02-16
Goldman Sachs
Top 30%
71
HoldDowngrades$173.00+20.38%2024-02-16
Needham
Top 19%
82
BuyReiterates$200.00+39.17%2024-02-15
Morgan Stanley
Top 7%
94
HoldMaintains$176.00+22.47%2024-02-13

1 of 2

Forecast return on equity

Is ALNY forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is ALNY forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ALNY revenue forecast

What is ALNY's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$1.8B+0.88%
Avg 2 year Forecast
$2.2B+22.16%
Avg 3 year Forecast
$3.3B+82.31%
ALNY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALNY revenue growth forecast

How is ALNY forecast to perform vs Biotechnology companies and vs the US market?
Company
19.79%
Industry
37.04%
Market
9.92%
ALNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALNY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALNY$143.71$213.58+48.62%Buy
GMAB$27.46$45.00+63.87%Buy
RPRX$28.11$46.75+66.31%Strong Buy
BNTX$86.71$114.71+32.30%Hold
BGNE$148.56$242.60+63.30%Strong Buy
View Top Biotech Stocks

Alnylam Pharmaceuticals Stock Forecast FAQ

Is Alnylam Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: ALNY) stock is to Buy ALNY stock.

Out of 12 analysts, 3 (25%) are recommending ALNY as a Strong Buy, 4 (33.33%) are recommending ALNY as a Buy, 5 (41.67%) are recommending ALNY as a Hold, 0 (0%) are recommending ALNY as a Sell, and 0 (0%) are recommending ALNY as a Strong Sell.

If you're new to stock investing, here's how to buy Alnylam Pharmaceuticals stock.

What is ALNY's revenue growth forecast for 2024-2026?

(NASDAQ: ALNY) Alnylam Pharmaceuticals's forecast annual revenue growth rate of 19.79% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Alnylam Pharmaceuticals's revenue in 2024 is $1,828,292,000.On average, 11 Wall Street analysts forecast ALNY's revenue for 2024 to be $232,297,065,471, with the lowest ALNY revenue forecast at $223,851,014,646, and the highest ALNY revenue forecast at $235,266,741,324. On average, 11 Wall Street analysts forecast ALNY's revenue for 2025 to be $281,287,963,815, with the lowest ALNY revenue forecast at $237,244,090,274, and the highest ALNY revenue forecast at $328,479,222,723.

In 2026, ALNY is forecast to generate $419,802,517,228 in revenue, with the lowest revenue forecast at $330,576,220,177 and the highest revenue forecast at $583,809,128,872.

What is ALNY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALNY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ALNY's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ALNY price target, the average ALNY price target is $213.58, with the highest ALNY stock price forecast at $395.00 and the lowest ALNY stock price forecast at $150.00.

On average, Wall Street analysts predict that Alnylam Pharmaceuticals's share price could reach $213.58 by Mar 27, 2025. The average Alnylam Pharmaceuticals stock price prediction forecasts a potential upside of 48.62% from the current ALNY share price of $143.71.

What is ALNY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALNY) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.